Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

MPR First Report - ACR/ARHP 2015

Live coverage of the 2015 ACR/ARHP Annual Meeting

Women See Less Relief With Rx

A new study in the Journal of Women's Health has found that younger women are less likely to experience pain relief with long-term use of opioids for chronic non-cancer pain compared to men of the same age.

Headaches in Pregnancy: When to Worry

Based on a new study published in Neurology, researchers have developed the first clinical recommendations for making diagnostic decisions regarding headaches in pregnant women.

Live Coverage from PAINWeek 2015

Long-Term Pain Relief With New Therapy

Patients who received a novel high frequency form of spinal cord stimulation (SCS) therapy experienced significantly greater, long-term relief for both chronic back and leg pain, when compared to a traditional low frequency form of SCS therapy.

Inhaled Cannabis for Neuropathic Pain

Inhaled cannabis had a significant effect on neuropathic pain that appears to be dose-dependent, in the first published research on cannabinoids for painful diabetic neuropathy in humans.

Exercise or Surgery for Knee Pain?

Arthroscopic surgery to relieve chronic knee pain in middle-aged and older patients is only temporarily effective and might be harmful.

Smokers Need More Anesthesia During Surgery

Smokers and patients exposed to secondhand smoke may require more anesthesia and opioids during surgery than nonsmokers.

First Combo Rx for Adolescent Migraines

Pernix announced that the FDA has approved Treximet (sumatriptan, naproxen sodium) for use in patients aged ≥12 for the acute treatment of migraine with or without aura.

News

New Study Proposes Strategies for Pain Control After Total Knee Replacement

A team-based care approach comprised of the patient, family members, orthopedic surgeon, and other healthcare practitioners for total knee replacement procedures, combined with newer pain management strategies, is critical for maximizing patient outcomes.

FDA Announces Large Action Plan in Effort to Reverse the Opioid Epidemic

The FDA has announced a new action plan designed to reassess their approach to opioid medications.

Are High-Dose Opioid Prescriptions to Blame for Overdoses?

A new study has found that 71% of patients who overdosed on opioid prescription painkillers were given higher doses than similar patients who had lower dose prescriptions.

FDA Approves New Autoinjector for Migraine Tx

Dr. Reddy's Laboratories announced that the Food and Drug Administration (FDA) has approved ZembraceSymTouch (sumatriptan succinate) subcutaneous injection for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.

Health Plan Initiative Found to Significantly Lower Opioid Dosing

A health plan initiative designed to change physicians' expectations involving opioid prescriptions has shown positive results in lowering dosage levels of patients receiving chronic opioid treatment (COT).

Featured courses from mycme

Debridement Training: Principles & PracticeExternal web site

This course offers clinicians a comprehensive review of the art and science ...

CME|CE 4.00 Credits

Pain Medicine ABA/ABPM Exam Question Bank (45 CME Credits)External web site

Access more than 700 pain medicine practice questions and review detailed rationales for ...

CME

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

Sign Up for Free e-newsletters